Since circulating levels of these isoforms reflect enhanced expression of the respective adhesion molecules (38), we postulate that overexpression of VCAM1 in COVID-19 patients could participate in massive recruitment of immune cells in the lung, contributing to lung injury and prolonged MV. Here, VCAM1 is linked to COVID-19.